REVANCE THERAPEUTICS INC shareholders Q3 2023

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

REVANCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SUSQUEHANNA INTERNATIONAL GROUP, LLP 195,300$2,240,0910.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 136,667$1,567,5700.00%
GTS SECURITIES LLC 14,000$160,5800.00%
SIGNATUREFD, LLC 838$9,6120.00%
Elequin Capital, LP 16$1840.00%
HighTower Advisors, LLC 300$1,0420.00%
BALDWIN BROTHERS LLC/MA 500$5,7350.00%
Tower Research Capital LLC (TRC) 939$10,7700.00%
Daiwa Securities Group Inc. 331$40.00%
Allworth Financial LP 132$1,5150.00%
D. E. Shaw & Co., Inc. 30,000$344,1000.00%
SIMPLEX TRADING, LLC 18,980$2170.00%
ROYAL BANK OF CANADA 72,263$830,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 308$3,5330.00%
BANK OF AMERICA CORP /DE/ 120,909$1,386,8270.00%
STIFEL FINANCIAL CORP 14,956$171,5450.00%
FIRST MANHATTAN CO. LLC. 7$800.00%
CENTRAL TRUST Co 50$5740.00%
Russell Investments Group, Ltd. 182$2,0880.00%
US BANCORP \DE\ 3,275$37,5640.00%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q3 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.